Related Experiment Video
Updated: Jan 28, 2026

Online Size-exclusion and Ion-exchange Chromatography on a SAXS Beamline
Published on: January 5, 2017
Development and Validation of UHPLC-MS/MS Method for the Determination of SAX and 5-OH-SAX in Human Plasma and Its
Lanlan Qiu1,2,3, Jinjin Zeng2, Jingjing Chen2
1School of Pharmacy, Jiangsu Medical College, Yancheng, China.
Abstract:
A highly sensitive and reliable ultrahigh performance liquid chromatography-tandem mass spectrometry method (UHPLC-MS/MS) has been developed for the quantification of saxagliptin (SAX) and its metabolite, 5-hydroxy saxagliptin (5-OH-SAX), in human plasma. Utilizing an ACE Excel 3 Super C18 column with electrospray ionization multiple reaction monitoring, this method achieves excellent linearity across the concentration ranges of 0.1-50 ng/mL for SAX and 0.2-100 ng/mL for 5-OH-SAX. The mean extraction recoveries are reported at 99.87% for SAX and 97.68% for 5-OH-SAX, with matrix effects maintained at 0.85 and 0.86, respectively. Both intraday and interday relative standard deviations are maintained below 15%. Furthermore, the developed method confirms appropriate short-term stability, satisfying the requirements for pharmaceutical analysis without residual effects. Significantly, this validated method applies to pharmacokinetic studies, providing crucial insights into the drug and metabolite behaviors during varying ingestion states, thus enhancing therapeutic efficacy and patient compliance through informed SAX administration.
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
In Vitro Drug Release Testing: Overview, Development and Validation
Reliability and Validity
Development of Analytical Methods
5-Number Summary
In a box plot, the minimum and maximum data values represent the lower and upper whiskers in the graph, and the median is designated as the center of the box in the chart. The first quartile and third...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

